{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T07:46:22Z","timestamp":1782459982388,"version":"3.54.5"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T00:00:00Z","timestamp":1782172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T00:00:00Z","timestamp":1782432000000},"content-version":"vor","delay-in-days":3,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100001003","name":"Boehringer Ingelheim","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001003","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004312","name":"Eli Lilly and Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004312","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"DOI":"10.1186\/s12882-026-05141-3","type":"journal-article","created":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T10:46:23Z","timestamp":1782211583000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Impact of educational interventions on clinician knowledge, adherence, and satisfaction utilizing a CKD care pathway in primary care"],"prefix":"10.1186","volume":"27","author":[{"given":"Jamie","family":"Green","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tracey","family":"Conti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria S.","family":"Kobylinski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evan R.","family":"Norfolk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa","family":"Weimer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahlam","family":"Elbedewe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manisha","family":"Jhamb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,23]]},"reference":[{"issue":"4","key":"5141_CR1","doi-asserted-by":"publisher","first-page":"S117","DOI":"10.1016\/j.kint.2023.10.018","volume":"105","author":"PE Stevens","year":"2024","unstructured":"Stevens PE, Ahmed SB, Carrero JJ, et al. KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney Int. 2024;105(4):S117\u2013314. https:\/\/doi.org\/10.1016\/j.kint.2023.10.018.","journal-title":"Kidney Int"},{"issue":"4","key":"5141_CR2","doi-asserted-by":"publisher","first-page":"e002806","DOI":"10.1136\/bmjdrc-2022-002806","volume":"10","author":"JB McGill","year":"2022","unstructured":"McGill JB, Haller H, Roy-Chaudhury P, et al. Making an impact on kidney disease in people with type 2 diabetes: the importance of screening for albuminuria. BMJ Open Diabetes Res Care. 2022;10(4):e002806. https:\/\/doi.org\/10.1136\/bmjdrc-2022-002806.","journal-title":"BMJ Open Diabetes Res Care"},{"key":"5141_CR3","doi-asserted-by":"publisher","unstructured":"Johansen KL, Chertow GM, Gilbertson DT, et al. US renal data system 2022 annual data report: epidemiology of Kidney disease in the United States. Am J Kidney Dis. 2023;81(3):A8\u201311. https:\/\/doi.org\/10.1053\/j.ajkd.2022.12.001.","DOI":"10.1053\/j.ajkd.2022.12.001"},{"key":"5141_CR4","unstructured":"Centers for Disease Control and Prevention. Chronic Kidney Disease in the United States, 2023. https:\/\/www.cdc.gov\/kidneydisease\/publications-resources\/CKD-national-facts.html."},{"issue":"10159","key":"5141_CR5","doi-asserted-by":"publisher","first-page":"2052","DOI":"10.1016\/S0140-6736(18)31694-5","volume":"392","author":"KJ Foreman","year":"2018","unstructured":"Foreman KJ, Marquez N, Dolgert A, et al. Forecasting life expectancy, years of life lost, and all-cause and cause-specific mortality for 250 causes of death: reference and alternative scenarios for 2016\u201340 for 195 countries and territories. Lancet. 2018;392(10159):2052\u201390. https:\/\/doi.org\/10.1016\/S0140-6736(18)31694-5.","journal-title":"Lancet"},{"issue":"3","key":"5141_CR6","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/s41581-021-00527-y","volume":"18","author":"AK Bello","year":"2022","unstructured":"Bello AK, Johnson DW. Educating primary healthcare providers about kidney disease. Nat Rev Nephrol. 2022;18(3):133\u20134. https:\/\/doi.org\/10.1038\/s41581-021-00527-y.","journal-title":"Nat Rev Nephrol"},{"issue":"6","key":"5141_CR7","doi-asserted-by":"publisher","first-page":"788","DOI":"10.7326\/M22-3228","volume":"176","author":"MM Cusick","year":"2023","unstructured":"Cusick MM, Tisdale RL, Chertow GM, Owens DK, Goldhaber-Fiebert JD. Population-Wide Screening for Chronic Kidney Disease: A Cost-Effectiveness Analysis. Ann Intern Med. 2023;176(6):788\u201397. https:\/\/doi.org\/10.7326\/M22-3228.","journal-title":"Ann Intern Med"},{"key":"5141_CR8","doi-asserted-by":"publisher","unstructured":"Smekal MD, Bello AK, Donald M, et al. Enhancing primary care capacity in chronic kidney disease management: a quality improvement educational initiative. BMJ Open. 2021;11(11). https:\/\/doi.org\/10.1136\/bmjopen-2020-046068.","DOI":"10.1136\/bmjopen-2020-046068"},{"key":"5141_CR9","doi-asserted-by":"publisher","unstructured":"Donald M, Smekal MD, Elliott MJ, McBrien K, Weaver RG, Manns BJ, et al. Online clinical pathway for chronic kidney disease management in primary care: a retrospective cohort study. BMC Nephrol. 2021;22(1). https:\/\/doi.org\/10.1186\/s12882-021-02533-5.","DOI":"10.1186\/s12882-021-02533-5"},{"issue":"5","key":"5141_CR10","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1053\/j.ajkd.2013.12.012","volume":"63","author":"P Komenda","year":"2014","unstructured":"Komenda P, Ferguson TW, Macdonald K, et al. Cost-effectiveness of Primary Screening for CKD: A Systematic Review. Am J Kidney Dis. 2014;63(5):789\u201397. https:\/\/doi.org\/10.1053\/j.ajkd.2013.12.012.","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"5141_CR11","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/j.ekir.2020.11.039","volume":"6","author":"B Stengel","year":"2021","unstructured":"Stengel B, Muenz D, Tu C, et al. Adherence to the Kidney Disease: Improving Global Outcomes CKD Guideline in Nephrology Practice Across Countries. Kidney Int Rep. 2021;6(2):437\u201348. https:\/\/doi.org\/10.1016\/j.ekir.2020.11.039.","journal-title":"Kidney Int Rep"},{"key":"5141_CR12","doi-asserted-by":"publisher","unstructured":"Bramlage P, Lanzinger S, Tittel SR, et al. Guidelines adherence in the prevention and management of chronic kidney disease in patients with diabetes mellitus on the background of recent European recommendations\u2014a registry-based analysis. BMC Nephrol. 2021;22(1). https:\/\/doi.org\/10.1186\/s12882-021-02394-y.","DOI":"10.1186\/s12882-021-02394-y"},{"key":"5141_CR13","unstructured":"Sequist TD, Holliday AM. Physician and patient tools to improve chronic kidney disease care. https:\/\/www.ajmc.com\/view\/physician-and-patient-tools-to-improve-chronic-kidney-disease-care"},{"issue":"5","key":"5141_CR14","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1053\/j.ajkd.2020.07.008","volume":"76","author":"K Foti","year":"2020","unstructured":"Foti K, Chang AR. CKD Management in Primary Care: Supporting Systems Change. Am J Kidney Dis. 2020;76(5):613\u20135. https:\/\/doi.org\/10.1053\/j.ajkd.2020.07.008.","journal-title":"Am J Kidney Dis"},{"issue":"5","key":"5141_CR15","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1053\/j.ajkd.2019.05.003","volume":"74","author":"KN Danforth","year":"2019","unstructured":"Danforth KN, Hahn EE, Slezak JM, et al. Follow-up of Abnormal Estimated GFR Results Within a Large Integrated Health Care Delivery System: A Mixed-Methods Study. Am J Kidney Dis. 2019;74(5):589\u2013600. https:\/\/doi.org\/10.1053\/j.ajkd.2019.05.003.","journal-title":"Am J Kidney Dis"},{"key":"5141_CR16","doi-asserted-by":"publisher","unstructured":"Hirsch JS, Danna SC, Desai N et al. Optimizing care delivery in patients with chronic kidney disease in the United States: proceedings of a multidisciplinary roundtable discussion and literature review. J Clin Med. 2024;13(5). https:\/\/doi.org\/10.3390\/jcm13051206","DOI":"10.3390\/jcm13051206"},{"key":"5141_CR17","doi-asserted-by":"publisher","unstructured":"Siddiqui K, George TP, Joy SS, Alfadda AA. Risk factors of chronic kidney disease among type 2 diabetic patients with longer duration of diabetes. Front Endocrinol (Lausanne). 2022;13. https:\/\/doi.org\/10.3389\/fendo.2022.1079725.","DOI":"10.3389\/fendo.2022.1079725"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-026-05141-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-026-05141-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-026-05141-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T06:54:29Z","timestamp":1782456869000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12882-026-05141-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,23]]},"references-count":17,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5141"],"URL":"https:\/\/doi.org\/10.1186\/s12882-026-05141-3","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,23]]},"assertion":[{"value":"11 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"IRB approval forms were submitted to the University of Pittsburgh Medical Center\u2019s Institutional Review Board Office of Research Protections and Geisinger Institutional Review Board. Protocols were reviewed and qualified for exemption under United States Department of Health and Human Services regulations [(45 CFR 46.104)]. Informed consent to participate was waived by the IRB because the study qualified for exemption under 45 CFR 46.104. The study was conducted in accordance with the ethical principles outlined in the Declaration of Helsinki and in compliance with applicable institutional and federal regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human ethics and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Manisha Jhamb, MD, MPH reports grants from Networks of Excellence during the conduct of the study and personal fees from Eli Lilly, Boehringer Ingelheim, Networks of Excellence, and Clinical Care Targeted Communications, LLC, as well as grants from Pfizer, Bayer, and Dialysis Clinic Inc., outside the submitted work. Alexander Chang, MD reports research funding from Boehringer Ingelheim, Novartis, and Bayer. Tracey Conti, MD reports consulting fees from Bayer.Evan R. Norfolk, MD reports consulting relationships with Petauri Kinect and Fresenius Medical Care. Ahlam Elbedewe is an employee of Petauri Kinect. The remaining authors (Jamie Green, MD, MS; Maria S. Kobylinski, MD; and Melissa Weimer, MS) declare that they have no competing interests.Funding and support for the development of this manuscript were provided by Boehringer Ingelheim and Eli Lilly. The funders had no role in the study design; data collection, analysis, or interpretation; manuscript preparation; or the decision to submit the manuscript for publication.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"386"}}